EAM Investors’s NEOPHOTONICS CORP NPTN Stock Holding History

EAM Investors’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-107,055	Closed	-$889K	–	347
2018 Q3	$889K	Buy	+107,055	New	+$814K	0.13%	234
2016 Q4	–	Sell	-265,134	Closed	-$4.33M	–	387
2016 Q3	$4.33M	Buy	+265,134	New	+$3.73M	0.58%	20
2016 Q2	–	Sell	-344,547	Closed	-$4.84M	–	393
2016 Q1	$4.84M	Sell	344,547 -140,215	-29%	-$1.45M	0.76%	7
2015 Q4	$5.26M	Buy	484,762 +220,413	+83%	+$1.99M	0.69%	7
2015 Q3	$1.8M	Sell	264,349 -560,551	-68%	-$4.34M	0.29%	165
2015 Q2	$7.53M	Buy	824,900 +455,256	+123%	+$3.45M	0.88%	2
2015 Q1	$2.5M	Buy	+369,644	New	+$1.49M	0.29%	170
2013 Q3	–	Sell	-348,324	Closed	-$3.03M	–	381
2013 Q2	$3.03M	Buy	+348,324	New	+$2.24M	0.66%	17

Other funds holding NPTN

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM Investors's NPTN Position: Q4 2018 in Review

EAM Investors sold out of NEOPHOTONICS CORP (NPTN) in Q4 2018, closing a stake of 107,055 shares — an estimated $889K sold.

EAM Investors first reported a position in NPTN in Q2 2013 and held it in 8 quarters. The position peaked at $7.53M in Q2 2015. 115 funds tracked by Wall St. Rank hold NPTN as of Q4 2018.

EAM Investors reported no remaining NEOPHOTONICS CORP position as of Q4 2018 after selling out during the quarter.
EAM Investors sold 107,055 NEOPHOTONICS CORP shares in Q4 2018, an estimated $889K.
EAM Investors first reported a position in NEOPHOTONICS CORP in Q2 2013 and held it in 8 quarters.
EAM Investors's NEOPHOTONICS CORP position peaked at $7.53M in Q2 2015.
115 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2018.

Based on EAM Investors's 13F filing for Q4 2018, filed 13 Feb 2019.